Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
SEC Filings
Home
SEC Filings
Filings
Filing Date
Form Type
Company
Description
AI
Link
Learn
MCP
API
Cookie Preferences
RTSN · Form 4 · Olds Donald – Retension Pharmaceuticals, Inc. | Signal8
Material events
Financial results
Capital raises
Insider transactions
Fund filings
Advanced filters
Any time
Sort
Filings
Filing Date
Form Type
Company
Description
AI
Link
Browse AI-analysed SEC filings
Page 1 of 76 · 7,582 total
CNP: 10-Q · periodic report
CNP · 10-Q · 2026-10-27
WDS: 6-K · asset sale
WDS · 6-K · 2026-10-27
HLT: 8-K · earnings release
HLT · 8-K · 2026-10-27
IONR: 6-K · periodic report
IONR · 6-K · 2026-10-27
VBIO: 8-K · material agreement
VBIO · 8-K · 2026-10-27
IBCP: 8-K · earnings release
IBCP · 8-K · 2026-10-27
PG: 424B5 · prospectus supplement
PG · 424B5 · 2026-10-27
AWI: 8-K · earnings release
AWI · 8-K · 2026-10-27
NMR: 6-K · foreign private issuer
NMR · 6-K · 2026-10-27
ATAT: 6-K · other
ATAT · 6-K · 2026-10-27
TII: 6-K · other
TII · 6-K · 2026-10-27
REXR: 10-Q · periodic report
REXR · 10-Q · 2026-10-27
WETO: 6-K · amendment
WETO · 6-K · 2026-10-27
CNC: 10-Q · periodic report
CNC · 10-Q · 2026-10-26
CPAC: 6-K · earnings release
CPAC · 6-K · 2026-10-26
CNC: 8-K · earnings release
CNC · 8-K · 2026-10-26
BMOOF: 6-K · material agreement
BMOOF · 6-K · 2026-10-26
ELE: 6-K · acquisition merger
ELE · 6-K · 2026-10-26
BETR: 8-K · leadership change
BETR · 8-K · 2026-10-26
NAUT: 8-K · earnings release
NAUT · 8-K · 2026-10-26
CMTV: 8-K · earnings release
CMTV · 8-K · 2026-10-26
PII: 8-K · earnings release
PII · 8-K · 2026-10-26
EGO: 6-K · other
EGO · 6-K · 2026-10-26
BFH: 10-Q · periodic report
BFH · 10-Q · 2026-10-26
ELP: 6-K · leadership change
ELP · 6-K · 2026-10-26
POAS: 6-K · other
POAS · 6-K · 2026-10-26
AMGN: 8-K · leadership change
AMGN · 8-K · 2026-10-26
BCSF: 8-K · earnings release
BCSF · 8-K · 2026-10-26
HYMC: 10-Q · periodic report
HYMC · 10-Q · 2026-10-26
BLX: 6-K · dividend
BLX · 6-K · 2026-10-26
VLRS: 6-K · earnings release
VLRS · 6-K · 2026-10-26
SNDL: 6-K · earnings release
SNDL · 6-K · 2026-10-26
AURE: SCHEDULE 13D/A · ownership disclosure
AURE · SCHEDULE 13D/A · 2026-10-27
GRML: S-1 · offering registration
GRML · S-1 · 2026-10-26
BEAG: 8-K · other
BEAG · 8-K · 2026-10-26
IQST: 8-K · debt financing
IQST · 8-K · 2026-10-26
CBK: 8-K · earnings release
CBK · 8-K · 2026-10-26
EVEX: 8-K · delisting
EVEX · 8-K · 2026-10-26
PHCI: 8-K · restatement
PHCI · 8-K · 2026-10-26
GGB: 6-K · dividend
GGB · 6-K · 2026-10-26
GGB: 6-K · earnings release
GGB · 6-K · 2026-10-26
WST: 8-K · debt financing
WST · 8-K · 2026-10-26
VENU: 8-K · material agreement
VENU · 8-K · 2026-10-26
AMUB: 424B3 · prospectus supplement
AMUB · 424B3 · 2026-10-26
GGB: 6-K · earnings release
GGB · 6-K · 2026-10-26
GRBK: 8-K · leadership change
GRBK · 8-K · 2026-10-26
AEYE: 10-Q · periodic report
AEYE · 10-Q · 2026-10-26
CYCU: 8-K · leadership change
CYCU · 8-K · 2026-10-26
DSY: 6-K · periodic report
DSY · 6-K · 2026-10-26
UBXG: 20-F · periodic report
UBXG · 20-F · 2026-10-26
PAX: 6-K · proxy statement
PAX · 6-K · 2026-10-26
BRO: 10-Q · periodic report
BRO · 10-Q · 2026-10-26
FLD: 424B3 · reverse split
FLD · 424B3 · 2026-10-26
FLD: 424B3 · reverse split
FLD · 424B3 · 2026-10-26
NE: 8-K · earnings release
NE · 8-K · 2026-10-26
BRO: 8-K · earnings release
BRO · 8-K · 2026-10-26
SLMT: SCHEDULE 13D/A · ownership disclosure
SLMT · SCHEDULE 13D/A · 2026-10-26
BBLG: 10-Q · periodic report
BBLG · 10-Q · 2026-10-26
WGRX: 8-K · acquisition merger
WGRX · 8-K · 2026-10-26
BRBS: 8-K · earnings release
BRBS · 8-K · 2026-10-26
YHNA: 8-K · delisting
YHNA · 8-K · 2026-10-26
CRML: 6-K · acquisition merger
CRML · 6-K · 2026-10-26
ZEO: 8-K · delisting
ZEO · 8-K · 2026-10-26
NUE: 8-K · earnings release
NUE · 8-K · 2026-10-26
BOH: 10-Q · periodic report
BOH · 10-Q · 2026-10-26
AMSS: 424B5 · prospectus supplement
AMSS · 424B5 · 2026-10-26
PULM: 424B3 · prospectus supplement
PULM · 424B3 · 2026-10-26
GNVR: 8-K · material agreement
GNVR · 8-K · 2026-10-26
SXI: 8-K · leadership change
SXI · 8-K · 2026-10-26
AMSS: 424B5 · prospectus supplement
AMSS · 424B5 · 2026-10-26
TRAW: S-1 · offering registration
TRAW · S-1 · 2026-10-26
DSY: 20-F · periodic report
DSY · 20-F · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
CEPU: 6-K · share repurchase
CEPU · 6-K · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
R: 424B3 · debt financing
R · 424B3 · 2026-10-26
SDEV: S-3/A · shelf registration
SDEV · S-3/A · 2026-10-26
FLXS: 8-K · earnings release
FLXS · 8-K · 2026-10-26
WEAV: 8-K · acquisition merger
WEAV · 8-K · 2026-10-26
WHLR: 424B3 · reverse split
WHLR · 424B3 · 2026-10-26
XHLD: 424B3 · shelf registration
XHLD · 424B3 · 2026-10-26
GLASF: 6-K · earnings release
GLASF · 6-K · 2026-10-26
SLBT: 6-K · earnings release
SLBT · 6-K · 2026-10-26
TBI: 8-K · leadership change
TBI · 8-K · 2026-10-26
NEWH: 8-K · material agreement
NEWH · 8-K · 2026-10-26
DHI: 8-K · leadership change
DHI · 8-K · 2026-10-26
FSUN: 8-K · earnings release
FSUN · 8-K · 2026-10-26
HTO: 10-Q · periodic report
HTO · 10-Q · 2026-10-26
HIT: 8-K · leadership change
HIT · 8-K · 2026-10-26
WELL: 8-K · earnings release
WELL · 8-K · 2026-10-26
LAZ: 10-Q · periodic report
LAZ · 10-Q · 2026-10-26
DORM: 8-K · earnings release
DORM · 8-K · 2026-10-26
MAAS: 20-F · periodic report
MAAS · 20-F · 2026-10-26
UUU: S-3 · shelf registration
UUU · S-3 · 2026-10-26
DEA: 10-Q · periodic report
DEA · 10-Q · 2026-10-26
VRME: 8-K · earnings release
VRME · 8-K · 2026-10-26
NTCL: 6-K · reverse split
NTCL · 6-K · 2026-10-26
FDUS: 8-K · debt financing
FDUS · 8-K · 2026-10-26
CLWT: 6-K · proxy statement
CLWT · 6-K · 2026-10-26
MCRB: 8-K · leadership change
MCRB · 8-K · 2026-10-26
1
2
3
4
8
12
16
20
24
28
32
36
40
44
48
52
56
60
64
68
72
76
Next ›
